In another report, low concentration of metformin (60 μM) in combination with genistein (2 μM) and lunasin (2 μM), increased the PTEN expression, inhibited the cancer stem cell-like cells CD133+CD44+ subpopulation, and reduced fatty acid synthase (FASN) expression in HCT116 cells [39]. Here, FASN is linked to cancer.